These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25033415)

  • 1. Solution-based indirect affinity selection mass spectrometry--a general tool for high-throughput screening of pharmaceutical compound libraries.
    O'Connell TN; Ramsay J; Rieth SF; Shapiro MJ; Stroh JG
    Anal Chem; 2014 Aug; 86(15):7413-20. PubMed ID: 25033415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of pulsed ultrafiltration-mass spectrometry.
    Johnson BM; Nikolic D; van Breemen RB
    Mass Spectrom Rev; 2002; 21(2):76-86. PubMed ID: 12373745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lead discovery for mammalian elongation of long chain fatty acids family 6 using a combination of high-throughput fluorescent-based assay and RapidFire mass spectrometry assay.
    Takamiya M; Sakurai M; Teranishi F; Ikeda T; Kamiyama T; Asai A
    Biochem Biophys Res Commun; 2016 Nov; 480(4):721-726. PubMed ID: 27793673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method for quantitative protein-ligand affinity measurements in compound mixtures.
    Annis DA; Shipps GW; Deng Y; Popovici-Müller J; Siddiqui MA; Curran PJ; Gowen M; Windsor WT
    Anal Chem; 2007 Jun; 79(12):4538-42. PubMed ID: 17500537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodiversity of small molecules--a new perspective in screening set selection.
    Petrone PM; Wassermann AM; Lounkine E; Kutchukian P; Simms B; Jenkins J; Selzer P; Glick M
    Drug Discov Today; 2013 Jul; 18(13-14):674-80. PubMed ID: 23454345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of high-throughput mass spectrometry to reduce false positives in protease uHTS screens.
    Adam GC; Meng J; Rizzo JM; Amoss A; Lusen JW; Patel A; Riley D; Hunt R; Zuck P; Johnson EN; Uebele VN; Hermes JD
    J Biomol Screen; 2015 Feb; 20(2):212-22. PubMed ID: 25336354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in the study of affinity selection-ultrafiltration/HPLC-MS].
    Zhao HY; Zhang YZ; Xiao CL
    Yao Xue Xue Bao; 2009 Oct; 44(10):1084-8. PubMed ID: 20055128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays.
    Chovan LE; Black-Schaefer C; Dandliker PJ; Lau YY
    Rapid Commun Mass Spectrom; 2004; 18(24):3105-12. PubMed ID: 15565734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Label-free screening assays: a strategy for finding better drug candidates.
    Lunn CA
    Future Med Chem; 2010 Nov; 2(11):1703-16. PubMed ID: 21428840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
    Bergsdorf C; Ottl J
    Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of ultra-high pressure liquid chromatography coupled to high resolution mass spectrometry for fast screening in high throughput doping control.
    Musenga A; Cowan DA
    J Chromatogr A; 2013 May; 1288():82-95. PubMed ID: 23540767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel SFC/MS-MUX screening to assess enantiomeric purity.
    Laskar DB; Zeng L; Xu R; Kassel DB
    Chirality; 2008 Aug; 20(8):885-95. PubMed ID: 18381739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplex enzyme assays and inhibitor screening by mass spectrometry.
    Rathore R; Pribil P; Corr JJ; Seibel WL; Evdokimov A; Greis KD
    J Biomol Screen; 2010 Sep; 15(8):1001-7. PubMed ID: 20228278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
    Sukuru SC; Jenkins JL; Beckwith RE; Scheiber J; Bender A; Mikhailov D; Davies JW; Glick M
    J Biomol Screen; 2009 Jul; 14(6):690-9. PubMed ID: 19531667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of a rapid automated solubility classification into early validation of hits obtained by high throughput screening.
    Fligge TA; Schuler A
    J Pharm Biomed Anal; 2006 Oct; 42(4):449-54. PubMed ID: 16797909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct analysis in real time--high resolution mass spectrometry as a valuable tool for the pharmaceutical drug development.
    Srbek J; Klejdus B; Douša M; Břicháč J; Stasiak P; Reitmajer J; Nováková L
    Talanta; 2014 Dec; 130():518-26. PubMed ID: 25159441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high throughput metabolic stability screening workflow with automated assessment of data quality in pharmaceutical industry.
    Xu R; Manuel M; Cramlett J; Kassel DB
    J Chromatogr A; 2010 Mar; 1217(10):1616-25. PubMed ID: 20132940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity selection-mass spectrometry and its emerging application to the high throughput screening of G protein-coupled receptors.
    Whitehurst CE; Annis DA
    Comb Chem High Throughput Screen; 2008 Jul; 11(6):427-38. PubMed ID: 18673271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the applicability of antibodies generated within the human protein atlas as capture agents in immunoenrichment coupled to mass spectrometry.
    Boström T; Johansson HJ; Lehtiö J; Uhlén M; Hober S
    J Proteome Res; 2014 Oct; 13(10):4424-35. PubMed ID: 25231543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.